期刊文献+

抑制CXCR4基因调控Wnt/β-catenin通路在卵巢癌转移中的作用 被引量:5

Blockage of CXCR4 affects the metastasis of ovarian cancer via Wnt/β-catenin signaling pathway
下载PDF
导出
摘要 目的研究趋化因子受体4(chemokine receptor 4,CXCR4)在卵巢癌转移中的作用及其机制。方法采用Real-time PCR和Western blot法检测正常卵巢组织、卵巢癌组织和卵巢癌细胞株(CAOV3)CXCR4mRNA和蛋白的表达以及CXCR4shRNA转染后卵巢癌CAOV3中CXCR4mRNA和蛋白的表达;MTT法检测CXCR4shRNA对卵巢癌细胞增殖的影响;通过Transwell侵袭实验检测CXCR4基因沉默对卵巢癌细胞侵袭性的作用;Real-time PCR法检测CXCR4shRNA转染后Wnt/β-catenin通路相关基因和EMT相关基因的mRNA表达。结果 CXCR4在卵巢癌组织和CAOV3细胞中的表达明显高于正常卵巢组织;转染CXCR4shRNA可有效抑制CAOV3细胞中CXCR4mRNA和蛋白表达;CXCR4基因沉默可有效抑制细胞增殖、降低细胞侵袭性;同时明显抑制Wnt/β-catenin通路相关基因CTNNBI、C-MYC、MMP-9和CD44以及EMT相关基因SLUG和Vimentin的mRNA表达。结论 CXCR4通过调控Wnt/β-catenin通路影响卵巢癌的转移。 Objective To determine the role and the possible mechanisms of chemokine receptor 4(CXCR4)in the metastasis of ovarian cancer.Methods Real-time PCR and Western blot were used to analyze the expression of CXCR4 in normal ovarian tissues,malignant epithelial ovarian tumors and ovarian cancer cell lines and the expression of CXCR4 in CAOV3 cell after transfected with shRNA against CXCR4.MTT assay and Transwell migration assay were used to detect the resulting alterations in cell proliferation and migration.Last,we detected the mRNA expression of Wnt/β-catenin related genes and EMT-related genes.Results CXCR4 was highly expressed in malignant ovarian tumors and ovarian cancer cell lines.CXCR4 expression was inhibited by shRNA against CXCR4.Knockdown of CXCR4 could obviously reduce the proliferation and invasion of ovarian cancer cells.Moreover,Wnt target genes(CTNNBI,C-MYC,MMP-9,and CD44)and mesenchymal markers such as Vimentin and SLUG were also inhibited by shRNA against CXCR4.Conclusion CXCR4 plays a critical role in the metastasis of human ovarian cancer through modulating the Wnt/β-catenin signaling pathway.
作者 王佳 王泽华
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第5期658-662,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 卵巢癌 趋化因子受体(CXCR4) WNT/Β-CATENIN RNA干扰 ovarian cancer chemokine receptor 4(CXCR4) Wnt/β-catenin RNA interference
  • 相关文献

参考文献16

  • 1TORRE LA, BRAY F0 SIEGEL RL, et al. Global cancer sta- tistics, 2012[J]. CA Cancer J Clin, 2016, 65(2) ,87-108.
  • 2MOSER B, WOLF M, WALZ A, et al. Chemokines: multiple levels of leukocyte migration control [J]- Trends Immunol, 2004, 25(2) :75-84.
  • 3GATCLIFFE TA, MONK BJ, PLANUTIS K, et al. Wnt sig-naling in ovarian tumorigenesis [J]. Int J Gynecol Cancer, 2008, 18(5) :954-962.
  • 4ZHAO JH, LUO Y, JIANG YG, et al. Knockdown of/3-cate- nin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-I[J]. Cancer Invest, 2011, 29 (6) :377-382.
  • 5LIVAK KJ, SCHMITTGEN TD. Analysis of relative gene ex- pression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method[J]. Methods, 2002, 25(4):402-408.
  • 6DOMANSKA UM, KRUIZINGA RC, NAGENGAST WB, et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide[J]. Eur J Cancer, 2012,49(1) :219-230.
  • 7LU Z, QI L, BO XJ, et al. Expression of CD26 and CXCR4 in prostate carcinoma and its relationship with clinical parameters [J]. J Res Med Sci, 2014, 18(8):647-652.
  • 8BURGER JA, STEWART DJ, WALD O, et al. Potential of CXCR4 antagonists for the treatment of metastatic lung cancer [J]. Expert Rev Anticancer Ther, 2011, 11(4) : 621-630.
  • 9GROS K/, KURSCHAT N, DRENCKHAN A, et al. Involve- ment of CXCR4 chemokine receptor in metastastic HER2-posi- tire esophageal cancer[J]. PLoS One, 2012, 7(10):e47287.
  • 10TOYOZAWA S, KAMINAKA C, FURUKAWA F, et al. Chemokine receptor CXCR4 is a novel marker for the progres-sion of cutaneous malignant melanomas [J]. Acta Histochem Cytochem, 2012, 45(5) :293-299.

二级参考文献12

  • 1蒋玉萍,吴小华,邢邯英,杜行严.趋化因子CXCL12及其受体CXCR4对卵巢上皮性癌细胞增殖、迁移和侵袭能力的影响[J].中华妇产科杂志,2007,42(6):403-407. 被引量:17
  • 2Brummelkamp TR,Bernards R,et al.A system for stable expression of short Interfering RNAs in mammalian cells.Science,2002,296(5567):550-553.
  • 3Payne AS,Cornelius LA.The role of chemokines in melanoma tumor growth and metastasis.Invest Dermatol,2002,118:915-922.
  • 4Jiang YP,Wu XH,Shi B,et al.Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer:an independent prognostic factor for tumor progression.Gynecol Oncol,2006,103:226-233.
  • 5Zhou N,Fang J,Mukhtar M,et al.Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.Gene Therapy,2004,11:1703-1712.
  • 6Kim CH,Broxmever HE.SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells:differential activity of ligands of CCR7,CXCR3,or CXCR4 in chemotaxis vs suppression of progenitor proliferation.Leukoc Biol,1999,66(3):455-461.
  • 7Bleul CC,Farzan M,Choe H,et al.The lymphocyte chemoattractan SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry.Nature,1996,382(6594):829-833.
  • 8Alkhatib G.The biology of CCR5 and CXCR4.Current Opinion in HIV and AIDS,2009,4:96-103.
  • 9Porcile C,Bajetto A,Barbero S,et al.CXCR4 Activation induces epidermal growth factor receptor transactivation in an ovarian cancer cell line.ANN N Y Acad Sci,2004,1030:162-169.
  • 10Scotton CJ,Wilson JL,Milliken D et al.Epithelial cancer cell migration:a role for chemokine receptors?Cancer Res,2001,61:4961-4965.

共引文献4

同被引文献59

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部